Comparative Significance of Invasive Measures of Microvascular Injury in Acute Myocardial Infarction

Annette M Maznyczka, Keith G Oldroyd, John P Greenwood, Peter J McCartney, James Cotton, Mitchell Lindsay, Margaret McEntegart, J Paul Rocchiccioli, Richard Good, Keith Robertson, Hany Eteiba, Stuart Watkins, Aadil Shaukat, Colin J Petrie, Aengus Murphy, Mark C Petrie, Colin Berry, Annette M Maznyczka, Keith G Oldroyd, John P Greenwood, Peter J McCartney, James Cotton, Mitchell Lindsay, Margaret McEntegart, J Paul Rocchiccioli, Richard Good, Keith Robertson, Hany Eteiba, Stuart Watkins, Aadil Shaukat, Colin J Petrie, Aengus Murphy, Mark C Petrie, Colin Berry

Abstract

Background: The resistive reserve ratio (RRR) expresses the ratio between basal and hyperemic microvascular resistance. RRR measures the vasodilatory capacity of the microcirculation. We compared RRR, index of microcirculatory resistance (IMR), and coronary flow reserve (CFR) for predicting microvascular obstruction (MVO), myocardial hemorrhage, infarct size, and clinical outcomes, after ST-segment-elevation myocardial infarction.

Methods: In the T-TIME trial (Trial of Low-Dose Adjunctive Alteplase During Primary PCI), 440 patients with acute ST-segment-elevation myocardial infarction from 11 UK hospitals were prospectively enrolled. In a subset of 144 patients, IMR, CFR, and RRR were measured post-primary percutaneous coronary intervention. MVO extent (% left ventricular mass) was determined by cardiovascular magnetic resonance imaging at 2 to 7 days. Infarct size was determined at 3 months. One-year major adverse cardiac events, heart failure hospitalizations, and all-cause death/heart failure hospitalizations were assessed.

Results: In these 144 patients (mean age, 59±11 years, 80% male), median IMR was 29.5 (interquartile range: 17.0-55.0), CFR was 1.4 (1.1-2.0), and RRR was 1.7 (1.3-2.3). MVO occurred in 41% of patients. IMR>40 was multivariably associated with more MVO (coefficient, 0.53 [95% CI, 0.05-1.02]; P=0.031), myocardial hemorrhage presence (odds ratio [OR], 3.20 [95% CI, 1.25-8.24]; P=0.016), and infarct size (coefficient, 5.05 [95% CI, 0.84-9.26]; P=0.019), independently of CFR≤2.0, RRR≤1.7, myocardial perfusion grade≤1, and Thrombolysis in Myocardial Infarction frame count. RRR was multivariably associated with MVO extent (coefficient, -0.60 [95% CI, -0.97 to -0.23]; P=0.002), myocardial hemorrhage presence (OR, 0.34 [95% CI, 0.15-0.75]; P=0.008), and infarct size (coefficient, -3.41 [95% CI, -6.76 to -0.06]; P=0.046). IMR>40 was associated with heart failure hospitalization (OR, 5.34 [95% CI, 1.80-15.81] P=0.002), major adverse cardiac events (OR, 4.46 [95% CI, 1.70-11.70] P=0.002), and all-cause death/ heart failure hospitalization (OR, 4.08 [95% CI, 1.55-10.79] P=0.005). RRR was associated with heart failure hospitalization (OR, 0.44 [95% CI, 0.19-0.99] P=0.047). CFR was not associated with infarct characteristics or clinical outcomes.

Conclusions: In acute ST-segment-elevationl infarction, IMR and RRR, but not CFR, were associated with MVO, myocardial hemorrhage, infarct size, and clinical outcomes. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT02257294.

Keywords: heart failure; hospitalization; magnetic resonance imaging; microcirculation; myocardial infarction.

Figures

Figure 1.
Figure 1.
Flow of subjects through the study. CFR indicates coronary flow reserve; CMR, cardiovascular magnetic resonance; IMR, index of microcirculatory resistance; MVO, microvascular obstruction; PCI, percutaneous coronary intervention; RRR, resistive reserve ratio; and STEMI, ST-segment–elevation myocardial infarction.
Figure 2.
Figure 2.
Scatterplots showing correlations between coronary physiology parameters. The following correlations are shown: (A) coronary flow reserve (CFR) and resistive reserve ratio (RRR); (B) index of microcirculatory resistance (IMR) and CFR; and (C) RRR and IMR. Also shown is discordance between dichotomized coronary physiology parameters and presence/absence of microvascular obstruction.
Figure 3.
Figure 3.
DeLong comparisons of receiver operating characteristic curves, showing performance of index of microcirculatory resistance (IMR), coronary flow reserve (CFR), and resistive reserve ratio (RRR). The predictive ability of IMR, CFR and RRR are shown for the following: (A) microvascular obstruction (MVO) presence/absence; (B) myocardial hemorrhage presence/absence; (C) hospitalization for heart failure; and (D) major adverse cardiac events.

References

    1. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, et al. ESC Scientific Document Group. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:119–177.. doi: 10.1093/eurheartj/ehx393
    1. Carrick D, Haig C, Ahmed N, McEntegart M, Petrie MC, Eteiba H, Hood S, Watkins S, Lindsay MM, Davie A, et al. Myocardial hemorrhage after acute reperfused ST-segment-elevation myocardial infarction: relation to microvascular obstruction and prognostic significance. Circ Cardiovasc Imaging. 2016;9:e004148 doi: 10.1161/CIRCIMAGING.115.004148
    1. Maznyczka AM, Oldroyd KG, McCartney P, McEntegart M, Berry C.The potential use of the index of microcirculatory resistance to guide stratification of patients for adjunctive therapy in acute myocardial infarction. JACC Cardiovasc Interv. 2019;12:951–966.. doi: 10.1016/j.jcin.2019.01.246
    1. Eitel I, de Waha S, Wöhrle J, Fuernau G, Lurz P, Pauschinger M, Desch S, Schuler G, Thiele H.Comprehensive prognosis assessment by CMR imaging after ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2014;64:1217–1226.. doi: 10.1016/j.jacc.2014.06.1194
    1. Fearon WF, Balsam LB, Farouque HM, Caffarelli AD, Robbins RC, Fitzgerald PJ, Yock PG, Yeung AC.Novel index for invasively assessing the coronary microcirculation. Circulation. 2003;107:3129–3132.. doi: 10.1161/01.CIR.0000080700.98607.D1
    1. Fiarresga A, Selas M, Oliveira E, Cavaco-Gonçalves S, Cacela D, Carrapiço B, Cardim N, Cruz Ferreira R.Invasive assessment of the coronary microcirculation using the index of microcirculatory resistance: description and validation of an animal model. Rev Port Cardiol. 2014;33:207–212.. doi: 10.1016/j.repc.2013.09.007
    1. Carrick D, Haig C, Carberry J, May VTY, McCartney P, Welsh P, Ahmed N, McEntegart M, Petrie MC, Eteiba H, et al. Microvascular resistance of the culprit coronary artery in acute ST-elevation myocardial infarction. JCI Insight. 2016;1:e85768 doi: 10.1172/jci.insight.85768
    1. De Maria GL, Alkhalil M, Wolfrum M, Fahrni G, Borlotti A, Gaughran L, Dawkins S, Langrish JP, Lucking AJ, Choudhury RP, et al. Index of microcirculatory resistance as a tool to characterize microvascular obstruction and to predict infarct size regression in patients with STEMI undergoing primary PCI. JACC Cardiovasc Imaging. 2019;12:837–848.. doi: 10.1016/j.jcmg.2018.02.018
    1. Ng MK, Yeung AC, Fearon WF.Invasive assessment of the coronary microcirculation: superior reproducibility and less hemodynamic dependence of index of microcirculatory resistance compared with coronary flow reserve. Circulation. 2006;113:2054–2061.. doi: 10.1161/CIRCULATIONAHA.105.603522
    1. McGeoch R, Watkins S, Berry C, Steedman T, Davie A, Byrne J, Hillis S, Lindsay M, Robb S, Dargie H, et al. The index of microcirculatory resistance measured acutely predicts the extent and severity of myocardial infarction in patients with ST-segment elevation myocardial infarction. JACC Cardiovasc Interv. 2010;3:715–722.. doi: 10.1016/j.jcin.2010.04.009
    1. Fearon WF, Low AF, Yong AS, McGeoch R, Berry C, Shah MG, Ho MY, Kim HS, Loh JP, Oldroyd KG.Prognostic value of the index of microcirculatory resistance measured after primary percutaneous coronary intervention. Circulation. 2013;127:2436–2441.. doi: 10.1161/CIRCULATIONAHA.112.000298
    1. Carrick D, Haig C, Ahmed N, Carberry J, Yue May VT, McEntegart M, Petrie MC, Eteiba H, Lindsay M, Hood S, et al. Comparative prognostic utility of indexes of microvascular function alone or in combination in patients with an acute ST-segment-elevation myocardial infarction. Circulation. 2016;134:1833–1847.. doi: 10.1161/CIRCULATIONAHA.116.022603
    1. Van Herck PL, Paelinck BP, Haine SE, Claeys MJ, Miljoen H, Bosmans JM, Parizel PM, Vrints CJ.Impaired coronary flow reserve after a recent myocardial infarction: correlation with infarct size and extent of microvascular obstruction. Int J Cardiol. 2013;167:351–356.. doi: 10.1016/j.ijcard.2011.12.099
    1. Layland J, Carrick D, McEntegart M, Ahmed N, Payne A, McClure J, Sood A, McGeoch R, MacIsaac A, Whitbourn R, et al. Vasodilatory capacity of the coronary microcirculation is preserved in selected patients with non-ST-segment-elevation myocardial infarction. Circ Cardiovasc Interv. 2013;6:231–236.. doi: 10.1161/CIRCINTERVENTIONS.112.000180
    1. Scarsini R, De Maria GL, Borlotti A, Kotronias RA, Langrish JP, Lucking AJ, Choudhury RP, Ferreira VM, Ribichini F, Channon KM, et al. Incremental value of coronary microcirculation resistive reserve ratio in predicting the extent of myocardial infarction in patients with STEMI. Insights from the Oxford Acute Myocardial Infarction (OxAMI) study. Cardiovasc Revasc Med. 2019;20:1148–1155.. doi: 10.1016/j.carrev.2019.01.022
    1. van der Hoeven NW, Janssens GN, de Waard GA, Everaars H, Broyd CJ, Beijnink CWH, van de Ven PM, Nijveldt R, Cook CM, Petraco R, et al. Temporal changes in coronary hyperemic and resting hemodynamic indices in nonculprit vessels of patients with ST-segment elevation myocardial infarction. JAMA Cardiol. 2019;4:736–744.. doi: 10.1001/jamacardio.2019.2138
    1. McCartney PJ, Eteiba H, Maznyczka AM, McEntegart M, Greenwood JP, Muir DF, Chowdhary S, Gershlick AH, Appleby C, Cotton JM, et al. T-TIME Group. Effect of low-dose intracoronary alteplase during primary percutaneous coronary intervention on microvascular obstruction in patients with acute myocardial infarction: a randomized clinical trial. JAMA. 2019;321:56–68.. doi: 10.1001/jama.2018.19802
    1. Aarnoudse W, Fearon WF, Manoharan G, Geven M, van de Vosse F, Rutten M, De Bruyne B, Pijls NH.Epicardial stenosis severity does not affect minimal microcirculatory resistance. Circulation. 2004;110:2137–2142.. doi: 10.1161/01.CIR.0000143893.18451.0E
    1. Yong AS, Layland J, Fearon WF, Ho M, Shah MG, Daniels D, Whitbourn R, Macisaac A, Kritharides L, Wilson A, et al. Calculation of the index of microcirculatory resistance without coronary wedge pressure measurement in the presence of epicardial stenosis. JACC Cardiovasc Interv. 2013;6:53–58.. doi: 10.1016/j.jcin.2012.08.019
    1. De Bruyne B, Pijls NH, Smith L, Wievegg M, Heyndrickx GR.Coronary thermodilution to assess flow reserve: experimental validation. Circulation. 2001;104:2003–2006.. doi: 10.1161/hc4201.099223
    1. De Maria GL, Alkhalil M, Borlotti A, Wolfrum M, Gaughran L, Dall’Armellina E, Langrish JP, Lucking AJ, Choudhury RP, Kharbanda RK, et al. Index of microcirculatory resistance-guided therapy with pressure-controlled intermittent coronary sinus occlusion improves coronary microvascular function and reduces infarct size in patients with ST-elevation myocardial infarction: the Oxford Acute Myocardial Infarction - Pressure-controlled Intermittent Coronary Sinus Occlusion study (OxAMI-PICSO study). EuroIntervention. 2018;14:e352–e359.. doi: 10.4244/EIJ-D-18-00378
    1. Bertomeu-González V, Bodí V, Sanchis J, Núñez J, López-Lereu MP, Peña G, Losada A, Gómez C, Chorro FJ, Llàcer A.[Limitations of myocardial blush grade in the evaluation of myocardial perfusion in patients with acute myocardial infarction and TIMI grade 3 flow]. Rev Esp Cardiol. 2006;59:575–581..
    1. Abaci A, Oguzhan A, Eryol NK, Ergin A.Effect of potential confounding factors on the thrombolysis in myocardial infarction (TIMI) trial frame count and its reproducibility. Circulation. 1999;100:2219–2223.. doi: 10.1161/01.cir.100.22.2219

Source: PubMed

3
구독하다